Tuesday, June 21st, 2016 - Persistence Market Research PVT. LTD.

The pharmaceutical industry is rapidly restructuring and going through tidal wave of changes in its drug discovery process. The businesses are opting for a model which is fully integrated and networked R&D. Increasing number of stages in the drug discovery process are being conducted through external collaborators and contract research organizations (CROs). Such rapid restructuring represents great challenges in implementation of the systems required for a collaborative research, and to further ensure that these networks operate efficiently, augment innovation, and at the same time lower the cost of drug discovery. Cloud-based drug discovery platforms are exclusively designed to help drug discovery companies to overcome the major hurdle of data, which has been created due to the fundamental restructuring of their research businesses.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/11020

Cloud-Based Drug Discovery Platform Market: Drivers & Restraints

Cloud-based computing is a way to help pharmaceutical researchers across the globe to form effective drug discovery teams without large investments in technology, computing resources or fixed running costs. The cloud-based platforms substantially reduces the overall time required in the drug discovery process. Toxicity prediction of a newly discovered drug is one of the restraints in the drug discovery process. Despite decades of unmatched funding by institutions, scientists are still facing problems in predicting the potent toxic side effects of a particular drug. The global cloud-based drug discovery platform market could be adversely affected by the huge investment requirements in the technical infrastructure for the identification of compounds that will cause a desired, optimum biological effect.

Cloud-Based Drug Discovery Platform Market: Segmentation

The global cloud-based drug discovery platform market is classified on the basis of region.

Cloud-Based Drug Discovery Platform Market: Overview

Scientists worldwide are attempting to discover newer drugs for treatment of more and more diseases than ever before. Currently, the drug discovery procedure involves identification of likely candidates, screening them to test biologically active and effective compounds. Discovery of a promising drug candidate quickly is a technical challenge for scientific researchers. But companies such as Microsoft Research have discovered a technological solution to this issue, a cloud-based drug discovery platform Molplex Clouds Against Disease. The company has used their computational platform deployed in the cloud to select 100 compounds from a trillion possible chemical structures which had the potential to be powerful drug agents against antibiotic-resistant bacteria. From these findings, the lab results provided 10 candidate structures with effective biological activity, further unveiling opportunities to treat a new type of antibiotic-resistant bacteria.

Cloud-Based Drug Discovery Platform Market: Region wise Overview

Geographically, global cloud-based drug discovery platform market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). Cloud-based drug discovery platform provides researchers an access to a state-of-the-art corporate data centre, wherein huge amount of data can be analysed efficiently. Global cloud-based drug discovery platform market is in its growth phase and its adoption is gaining momentum. Cloud-based drug discovery platform providers are accumulated in the U.S., U.K., Canada and few other European countries. As a result, North America and Europe regions are expected to account for more than half the share in the cloud-based drug discovery platform market.

Cloud-Based Drug Discovery Platform Market: Key Players

The key players in global cloud-based drug discovery platform market are Microsoft, BIOVIA, AstraZeneca, Accenture, Collaborative Drug Discovery, Inc., BioXcel Corporation, twoXAR, Incorporated, Seven Bridges, IBM to name a few. A major trend witnessed in the global cloud-based drug discovery platform is collaborations, particularly of drug discovery companies, universities, software and research companies, cloud management companies and so on. Such collaborative partnerships are enabling drug discovery companies to develop clouds against diseases while offering a high-quality drug discovery service based on a new molecular discovery platform that associates its power from cloud computing.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Rest Of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Rest Of Western Europe)
  • Eastern Europe (Russia, Rest Of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa and Rest Of MEA)

To Buy this Full Report: http://www.persistencemarketresearch.com/checkout/11020

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

PMR for Journalist: http://www.persistencemarketresearch.com/page/journalist-resources.asp

Contact Profile

Persistence Market Research PVT. LTD.


Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We understand that each client has a unique problem statement, and address it with our strengths. 


PMR
P: +1-646-568-7751
W: www.persistencemarketresearch.com/

Keywords

Cloud-Based Drug Discovery Platform Market

Categories

Newsrooms

Sharing

More Formats